Reuters logo
BRIEF-Theraclion publishes clinical trial results
August 28, 2017 / 4:07 PM / 4 months ago

BRIEF-Theraclion publishes clinical trial results

Aug 28 (Reuters) - THERACLION SA:

* THERACLION REPORTS PUBLICATION OF PROMISING CLINICAL TRIAL RESULTS IN A NEW THYROID INDICATION

* A REMISSION RATE AT 12 MONTHS EQUAL TO 73.3% (SUPPRESSION OF HYPERTHYROIDISM),

* NO ALTERATION OF OTHER ANTI-THYROID ANTIBODY LEVELS NOR OPHTHALMIC PARAMETERS

* A SIGNIFICANT DECREASE IN TITERS OF AUTOANTIBODIES (ANTI TSHR)

* FEASIBILITY AND PROBABLY FAVORABLE COST EFFECTIVENESS COMPARED TO SURGERY FOR ALL PATIENTS WHO RECEIVED SINGLE SESSION, BILATERAL PROCEDURE Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below